mTOR pathway activation in cutaneous melanoma is associated with poorer prognosis characteristics
mTOR pathway activation in cutaneous melanoma is associated with poorer prognosis characteristics is a paper indexed in ScholarIQ from OpenAlex.
How many citations does mTOR pathway activation in cutaneous melanoma is associated with poorer prognosis characteristics have?
mTOR pathway activation in cutaneous melanoma is associated with poorer prognosis characteristics has 41 citations in the OpenAlex counts ScholarIQ stores.
When was mTOR pathway activation in cutaneous melanoma is associated with poorer prognosis characteristics published?
mTOR pathway activation in cutaneous melanoma is associated with poorer prognosis characteristics has 2010 year in the ScholarIQ index.
What is the open-access status of mTOR pathway activation in cutaneous melanoma is associated with poorer prognosis characteristics?
mTOR pathway activation in cutaneous melanoma is associated with poorer prognosis characteristics has closed oa status in the ScholarIQ index.
What is the DOI of mTOR pathway activation in cutaneous melanoma is associated with poorer prognosis characteristics?
The DOI for mTOR pathway activation in cutaneous melanoma is associated with poorer prognosis characteristics is on the source record.
What is the PMID of mTOR pathway activation in cutaneous melanoma is associated with poorer prognosis characteristics?
The PMID for mTOR pathway activation in cutaneous melanoma is associated with poorer prognosis characteristics is on the source record.
What is the OpenAlex record for mTOR pathway activation in cutaneous melanoma is associated with poorer prognosis characteristics?
The OpenAlex for mTOR pathway activation in cutaneous melanoma is associated with poorer prognosis characteristics is on the source record.